Research / FTI / Fundamental state Inspectable configuration
State dimensions Filing 0001681459-25-000079 General Corporate
Debt relative to revenue 25th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.debt_to_revenue
40.51% · OPTIONAL · VALID
Capex intensity 70th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.capex_revenue_ratio
2.77% · OPTIONAL · VALID
Operating cash generation 100th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
19.78% · OPTIONAL · VALID
Revenue growth 55th Own-history percentile · N=20
Evidence method Yoy · gp.fundamentals.revenue
9.38% · CORE · VALID
Inventory pressure 50th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
52.78% · OPTIONAL · VALID
Gross margin RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.gross_margin
20.46% · CORE · NOT_ENOUGH_HISTORY
Operating margin 80th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.operating_margin
12.45% · CORE · VALID
R&D intensity 30th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
0.86% · OPTIONAL · VALID
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 39 states Self-history eligible
Sep 30, 2021 7/7 normalized Level 3 Dec 31, 2021 7/8 normalized Level 3 Mar 31, 2022 7/7 normalized Level 3 Jun 30, 2022 7/7 normalized Level 3 Sep 30, 2022 7/7 normalized Level 3 Dec 31, 2022 7/8 normalized Level 3 Mar 31, 2023 7/7 normalized Level 3 Jun 30, 2023 7/7 normalized Level 3 Sep 30, 2023 7/7 normalized Level 3 Dec 31, 2023 7/8 normalized Level 3 Mar 31, 2024 7/7 normalized Level 3 Jun 30, 2024 7/7 normalized Level 3 Sep 30, 2024 7/7 normalized Level 3 Dec 31, 2024 8/9 normalized Level 3 Mar 31, 2025 7/8 normalized Level 3 Jun 30, 2025 8/8 normalized Level 3 Sep 30, 2025 7/7 normalized Level 3 Dec 31, 2025 8/8 normalized Level 3 Mar 31, 2026 7/7 normalized Level 3 Jun 30, 2026 7/7 normalized Level 4 Period transition
What moved in the state? Balance Sheet Leverage Increased
Previous 9.75%
Current 40.51%
Delta 30.77% Capex Intensity Decreased
Previous 3.10%
Current 2.77%
Delta -0.33% Cash Generation Increased
Previous 10.58%
Current 19.78%
Delta 9.20% Growth Decreased
Previous 16.09%
Current 9.38%
Delta -6.71% Inventory Pressure Increased
Previous 11.85%
Current 52.78%
Delta 40.92% Margin Increased
Previous 18.95%
Current 20.46%
Delta 1.51% Profitability Decreased
Previous 12.74%
Current 12.45%
Delta -0.29% R And D Intensity Increased
Previous 0.81%
Current 0.86%
Delta 0.05% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.